Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

In the recent past, we observed an increased risk of cancer in the population with human immunodeficiency virus (HIV) owing to the development of antiretroviral therapies that decreased mortality caused by HIV-specific infections. This particularly fragile population is frequently excluded from clin...

Full description

Bibliographic Details
Main Authors: Lise Bertin, MD, Anthony Canellas, MD, Baptiste Abbar, MD, Marianne Veyri, Jean-Philippe Spano, MD, PhD, Jacques Cadranel, MD, PhD, Armelle Lavolé, MD
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:JTO Clinical and Research Reports
Subjects:
HIV
Anti–PD-1
CD4+
Viral load
Lung cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321001065

Internet

http://www.sciencedirect.com/science/article/pii/S2666364321001065

Similar Items